Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Global Head and Neck Cancer Disease Analysis 2017-2026: Forecasts, Treatment, Marketed Drugs & Pipeline | ||
By: PR Newswire Association LLC. - 15 Feb 2018 | Back to overview list |
|
DUBLIN, Feb. 15, 2018 /PRNewswire/ -- The "Disease Analysis: Head and Neck Cancer" report has been added to ResearchAndMarkets.com's offering. Head and neck cancer is the sixth most common cancer worldwide, and includes malignancies that can originate in the oral cavity, salivary glands, sinuses, and throat. Around 90% of cases have an epithelial origin, which present as squamous cell carcinomas. Environmental factors such as tobacco smoking and alcohol consumption greatly increase the risk of developing head and neck cancers. If diagnosed at an early stage, treatment for these cancers can be curative; however, the majority of patients are diagnosed when the disease is advanced, resulting in the need for more than one treatment modality. Market Snapshot
Key Topics Covered:
Treatment: Head And Neck Cancer (Published On 15 September 2017)
Epidemiology: Head And Neck Cancer (Published On 08 August 2017)
Marketed Drugs: Head And Neck Cancer (Published On 01 December 2017)
Pipeline: Head And Neck Cancer (Published On 01 December 2017)
For more information about this report visit https://www.researchandmarkets.com/research/z49sf7/global_head_and?w=5 Media Contact: Laura Wood, Senior Manager View original content:http://www.prnewswire.com/news-releases/global-head-and-neck-cancer-disease-analysis-2017-2026-forecasts-treatment-marketed-drugs--pipeline-300599379.html SOURCE Research and Markets |
||
|
||
Copyright 2018 PR Newswire Association LLC. | Back to overview list |